FollowMyHealth Patient Portal

Gerald L. Andriole Jr., MD

Robert Killian Royce Distinguished Professor
Professor, Surgery
Chief, Division of Urologic Surgery
Director, Men's Health Center

Specialty Areas

Urologic Surgery
Urologic Oncology
Prostate Cancer

Board Certifications

Urology

Hospital Affiliations

Progress West Hospital
Barnes-Jewish Hospital
Barnes-Jewish West County Hospital
St. Louis Children's Hospital
VA Medical Center - St. Louis

Areas of Clinical Interest

Prostate cancer, benign prostate hyperplasia, prostatectomy, penile cancer, bladder cancer, PSA, prostate specific antigen, BPH, kidney tumors, kidney cancer

  • Maps & Directions
  • Education
  • Publication & Research
  • In the News
  • Financial Disclosures

Maps & Directions

Maps & Directions

Siteman Cancer Center - South County

5225 MidAmerica Plaza
St. Louis, MO 63129
Phone: 314-747-7222

Barnes-Jewish West County Hospital
Medical Building One

1040 N. Mason Road
Creve Coeur, MO 63141

Suite: Suite 122,
Barnes-Jewish West County Hospital
Office Phone: 314-362-8200
Fax: 314-361-2203

Center for Advanced Medicine
Urologic Surgery Center

4921 Parkview Place
St. Louis, MO 63110

Suite: C
Floor: 11
Office Phone: 314-362-8200
Fax: 314-361-2203

Education

Education

Fellowship: National Cancer Institute 1985
Residency: Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 1983
Residency: Surgery, Strong Memorial Hospital, University of Rochester, Rochester, New York 1980
Medical School: Jefferson Medical College, Philadelphia 1978
B.S.Accelerated Med.: Pennsylvania State University, State College, PA 1976

Publication & Research

Publication & Research

Racial differences in prostate inflammation: results from the REDUCE study.
Vidal AC, Chen Z, Howard LE, Moreira DM, Castro-Santamaria R, Andriole GL, Taioli E, Fowke JH, Knudsen B, Drake CG, Nickel JC, Freedland SJ
Oncotarget. 2016 Jul 18; doi: 10.18632/oncotarget.10690.

PMID:
    27494864
    [PubMed - as supplied by publisher]
Related citations


Decreased Consumption of Branched-Chain Amino Acids Improves Metabolic Health.
Fontana L, Cummings NE, Arriola Apelo SI, Neuman JC, Kasza I, Schmidt BA, Cava E, Spelta F, Tosti V, Syed FA, Baar EL, Veronese N, Cottrell SE, Fenske RJ, Bertozzi B, Brar HK, Pietka T, Bullock AD, Figenshau RS, Andriole GL, Merrins MJ, Alexander CM, Kimple ME, Lamming DW
Cell Rep. 2016 Jul 12; 16(2)520-30. doi: 10.1016/j.celrep.2016.05.092.

PMID:
    27346343
    [PubMed - in process]
Related citations


Urinary Metabolomics Identifies a Molecular Correlate of Interstitial Cystitis/Bladder Pain Syndrome in a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Cohort.
Parker KS, Crowley JR, Stephens-Shields AJ, van Bokhoven A, Lucia MS, Lai HH, Andriole GL, Hooton TM, Mullins C, Henderson JP
EBioMedicine. 2016 May; 7167-74. doi: 10.1016/j.ebiom.2016.03.040.

PMID:
    27322470
    [PubMed - in process]
Related citations


Prostate MRI: a national survey of Urologist's attitudes and perceptions.
Manley BJ, Brockman JA, Raup VT, Fowler KJ, Andriole GL
Int Braz J Urol. 2016 May-Jun; 42(3)464-71. doi: 10.1590/S1677-5538.IBJU.2015.0235.

PMID:
    27286108
    [PubMed - in process]
Related citations


Electronic nutritional intake assessment in patients with urolithiasis: A decision impact analysis.
Heningburg AM, Mohapatra A, Potretzke AM, Park A, Paradis AG, Vetter J, Kuxhausen AN, McIntosh LD, Juehne A, Desai AC, Andriole GL, Benway BM
Investig Clin Urol. 2016 May; 57(3)196-201. doi: 10.4111/icu.2016.57.3.196.

PMID:
    27195318
    [PubMed - in process]
Related citations


Symptom Variability and Early Symptom Regression in the MAPP Study, a Prospective Study of Urological Chronic Pelvic Pain Syndrome.
Stephens-Shields AJ, Clemens JQ, Jemielita T, Farrar J, Sutcliffe S, Hou X, Landis JR, MAPP Research Network
J Urol. 2016 Apr 27; pii: S0022-5347(16)30310-X. doi: 10.1016/j.juro.2016.04.070.

PMID:
    27131464
    [PubMed - as supplied by publisher]
Related citations


Improved biopsy efficiency with MR/ultrasound fusion-guided prostate biopsy.
Kim EH, Andriole GL
J Natl Cancer Inst. 2016 Sep; 108(9)pii: djw040. doi: 10.1093/jnci/djw040.

PMID:
    27130934
    [PubMed - in process]
Related citations


The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE Study.
Jamnagerwalla J, Howard LE, Vidal AC, Moreira DM, Castro-Santamaria R, Andriole GL, Freedland SJ
J Urol. 2016 Apr 5; pii: S0022-5347(16)30127-6. doi: 10.1016/j.juro.2016.03.172.

PMID:
    27060053
    [PubMed - as supplied by publisher]
Related citations


Systemic Nonurological Symptoms in Patients with Overactive Bladder.
Lai HH, Vetter J, Jain S, Andriole GL
J Urol. 2016 Aug; 196(2)467-72. doi: 10.1016/j.juro.2016.02.2974.

PMID:
    26997309
    [PubMed - in process]
Related citations


Editorial Comment.
Kim EH, Andriole GL
Urology. 2016 May; 9117. doi: 10.1016/j.urology.2015.12.068.

PMID:
    26992812
    [PubMed - in process]
Related citations


Baseline subject characteristics predictive of compliance with study-mandated prostate biopsy in men at risk of prostate cancer: results from REDUCE.
Fischer S, Sun S, Howard LE, Moreira DM, Castro-Santamaria R, Andriole GL, Vidal AC, Freedland SJ
Prostate Cancer Prostatic Dis. 2016 Jun; 19(2)202-8. doi: 10.1038/pcan.2016.5.

PMID:
    26926927
    [PubMed - in process]
Related citations


Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study.
Moreira DM, Nickel JC, Andriole GL, Castro-Santamaria R, Freedland SJ
Prostate Cancer Prostatic Dis. 2016 Jun; 19(2)180-4. doi: 10.1038/pcan.2015.66.

PMID:
    26782712
    [PubMed - in process]
Related citations


Presence of Magnetic Resonance Imaging Suspicious Lesion Predicts Gleason 7 or Greater Prostate Cancer in Biopsy-Naive Patients.
Weaver JK, Kim EH, Vetter JM, Fowler KJ, Siegel CL, Andriole GL
Urology. 2016 Feb; 88119-24. doi: 10.1016/j.urology.2015.10.023.

PMID:
    26545849
    [PubMed - indexed for MEDLINE]
Related citations


NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.
Manda KR, Tripathi P, Hsi AC, Ning J, Ruzinova MB, Liapis H, Bailey M, Zhang H, Maher CA, Humphrey PA, Andriole GL, Ding L, You Z, Chen F
Oncogene. 2016 Jun 23; 35(25)3282-92. doi: 10.1038/onc.2015.389.

PMID:
    26477312
    [PubMed - in process]
Related citations


Use of Medical Therapy and Success of Laser Surgery and Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia.
Strope SA, Vetter J, Elliott S, Andriole GL, Olsen MA
Urology. 2015 Dec; 86(6)1115-22. doi: 10.1016/j.urology.2015.07.019.

PMID:
    26375848
    [PubMed - indexed for MEDLINE]
Related citations


Metformin use and risk of prostate cancer: results from the REDUCE study.
Feng T, Sun X, Howard LE, Vidal AC, Gaines AR, Moreira DM, Castro-Santamaria R, Andriole GL, Freedland SJ
Cancer Prev Res (Phila). 2015 Nov; 8(11)1055-60. doi: 10.1158/1940-6207.CAPR-15-0141.

PMID:
    26353947
    [PubMed - in process]
Related citations


Impact of childhood and recent traumatic events on the clinical presentation of overactive bladder.
Lai HH, Morgan CD, Vetter J, Andriole GL
Neurourol Urodyn. 2015 Sep 1; doi: 10.1002/nau.22872.

PMID:
    26332868
    [PubMed - as supplied by publisher]
Related citations


Management of Benign Prostatic Hyperplasia.
Kim EH, Larson JA, Andriole GL
Annu Rev Med. 2016; 67137-51. doi: 10.1146/annurev-med-063014-123902.

PMID:
    26331999
    [PubMed - in process]
Related citations


Genome-wide association study of prostate cancer-specific survival.
Szulkin R, Karlsson R, Whitington T, Aly M, Gronberg H, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Southey MC, FitzGerald LM, Henderson BE, Schumacher FR, Haiman CA, Sipeky C, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Lubiński J, Kluźniak W, Cannon-Albright L, Brenner H, Herrmann V, Holleczek B, Park JY, Sellers TA, Lim HY, Slavov C, Kaneva RP, Mitev VI, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, PRACTICAL consortium, Batra J, Clements JA, Australian Prostate Cancer BioResource, Albanes D, Andriole GL, Berndt SI, Chanock S, Gapstur SM, Giovannucci EL, Hunter DJ, Kraft P, Le Marchand L, Ma J, Mondul AM, Penney KL, Stampfer MJ, Stevens VL, Weinstein SJ, Trichopoulou A, Bueno-de-Mesquita BH, Tjønneland A, Cox DG, BPC3 consortium, Maehle L, Schleutker J, Lindström S, Wiklund F
Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11)1796-800. doi: 10.1158/1055-9965.EPI-15-0543.

PMID:
    26307654
    [PubMed - indexed for MEDLINE]
Related citations


Prostate cancer: A simplified prostate cancer grading system.
Kim EH, Andriole GL
Nat Rev Urol. 2015 Nov; 12(11)601-2. doi: 10.1038/nrurol.2015.212.

PMID:
    26304009
    [PubMed - indexed for MEDLINE]
Related citations

In the News

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians work collaboratively with pharmaceutical or medical device companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our faculty physicians are paid by these commercial companies to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this web site, physicians earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following earned financial interests during calendar year 2015.

Company Name: Augmenix

Royalties:

Equity: Yes

Consulting/Advisory Board:

Speaker Fees:

Reporting Date: May 01, 2016